HedgePath Pharmaceuticals, Inc. (6)

Browse by Contract Category

Contracts

Letter Agreement for Term Debt Facility, dated December 12, 2020, between the Company and Mayne Pharma (Filed With SEC on December 17, 2020)
Sublicense Agreement, dated August 27, 2019, by and between Mayne Pharma International Pty Ltd and the Company (Certain information has been redacted in the marked portions of the... (Filed With SEC on November 7, 2019)
Third Amended and Restated Supply and License Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)
Promissory Note, dated May 2, 2020, by and between the Company and Citibank, N.A (Filed With SEC on May 6, 2020)
Amended and Restated Sublicense Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)
Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)